Literature DB >> 18462080

HTLV type 1 molecular study in Brazilian villages with African characteristics giving support to the post-Columbian introduction hypothesis.

Filipe Ferreira de Almeida Rego1, Luiz Carlos Junior Alcantara, Jose Pereira Moura Neto, Aline Cristina Andrade Mota Miranda, Osmario de Souza Pereira, Marilda de Souza Gonçalves, Bernardo Galvão-Castro.   

Abstract

We performed an HTLV epidemiological study of 986 individuals from 17 villages from the same state of Salvador, the city with the highest HTLV-1 prevalence in Brazil. The HTLV-1 prevalence was 3.85%, 1.56%, and 1.23% in three villages. Phylogenetic analysis of the LTR region demonstrated that all positive samples analyzed belonged to the Transcontinental subgroup of the HTLV-1 Cosmopolitan subtype. Three of the new HTLV-1 sequences formed a well-supported clade within one of the Latin American clusters that contain a South African sequence. This Latin American cluster that segregated from the same ancestor as the other clade contained a Central African sequence. This ancestral relationship could support our previous report that suggests that this subgroup was first introduced into South Africa as a result of the migration of the Bantu population from Central Africa to Southern Africa over the past 3000 years, and afterward to Brazil during the slave trade between the sixteenth and nineteenth centuries.

Entities:  

Mesh:

Year:  2008        PMID: 18462080     DOI: 10.1089/aid.2007.0290

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  10 in total

1.  Tax gene characterization of human T-lymphotropic virus type 1 strains from Brazilian HIV-coinfected patients.

Authors:  Mariana Cavalheiro Magri; Luis Fernando de Macedo Brigido; Rosangela Rodrigues; Helena Kaminami Morimoto; Adele Caterino-de-Araujo
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-20       Impact factor: 2.205

2.  Mother-to-Child Transmission of Human T-Cell Lymphotropic Viruses-1/2: What We Know, and What Are the Gaps in Understanding and Preventing This Route of Infection.

Authors:  A B F Carneiro-Proietti; M S Amaranto-Damasio; C F Leal-Horiguchi; R H C Bastos; G Seabra-Freitas; D R Borowiak; M A Ribeiro; F A Proietti; A S D Ferreira; M L Martins
Journal:  J Pediatric Infect Dis Soc       Date:  2014-09       Impact factor: 3.164

3.  Phylogenetic and similarity analysis of HTLV-1 isolates from HIV-coinfected patients from the south and southeast regions of Brazil.

Authors:  Mariana Cavalheiro Magri; Luis Fernando de Macedo Brigido; Rosangela Rodrigues; Helena Kaminami Morimoto; João Leandro de Paula Ferreira; Adele Caterino-de-Araujo
Journal:  AIDS Res Hum Retroviruses       Date:  2011-06-24       Impact factor: 2.205

4.  Integrative and Multidisciplinary Care for People Living With Human T-Cell Lymphotropic Virus in Bahia, Brazil: 20 Years of Experience.

Authors:  Bernardo Galvão-Castro; Maria Fernanda Rios Grassi; Ana Verena Galvão-Castro; Aidê Nunes; Ana Karina Galvão-Barroso; Thessika Hialla Almeida Araújo; Regina Helena Rathsam-Pinheiro; Ceuci Lima Xavier Nunes; Adriele Ribeiro; Monique Lírio; Noilson Lázaro Gonçalves; Sônia Lúcia Rangel; Cristiane Maria Carvalho Costa Dias; Daniele Piai Ozores; Selena Márcia Dubois-Mendes; Isabela Lima; André Luís Pereira Silva; Washington Luiz Abreu de Jesus; Fred Luciano Neves Santos; José Guilherme Reis de Oliveira; Yscela Vanessa Pimentel de Moraes; Adijeane Oliveira de Jesus; Francisco Daltro; Ney Boa-Sorte; Humberto Castro-Lima; Maria Luísa Carvalho Soliani
Journal:  Front Med (Lausanne)       Date:  2022-06-07

5.  An overview of sequencing technology platforms applied to HTLV-1 studies: a systematic review.

Authors:  Felipe de Oliveira Andrade; Marina Silveira Cucco; Melina Mosquera Navarro Borba; Reinaldo Conceição Neto; Luana Leandro Gois; Filipe Ferreira de Almeida Rego; Luciane Amorim Santos; Fernanda Khouri Barreto
Journal:  Arch Virol       Date:  2021-08-20       Impact factor: 2.574

6.  Colonial history and contemporary transmission shape the genetic diversity of hepatitis C virus genotype 2 in Amsterdam.

Authors:  Peter V Markov; Thijs J van de Laar; Xiomara V Thomas; Sem J Aronson; Christine J Weegink; Guido E van den Berk; Maria Prins; Oliver G Pybus; Janke Schinkel
Journal:  J Virol       Date:  2012-05-09       Impact factor: 5.103

7.  Evidence of New Endemic Clusters of Human T-Cell Leukemia Virus (HTLV) Infection in Bahia, Brazil.

Authors:  Felicidade Mota Pereira; Maria da Conceição Chagas de Almeida; Fred Luciano Neves Santos; Roberto Perez Carreiro; Carlos Gustavo Regis-Silva; Bernardo Galvão-Castro; Maria Fernanda Rios Grassi
Journal:  Front Microbiol       Date:  2019-05-14       Impact factor: 5.640

Review 8.  Molecular epidemiology, genetic variability and evolution of HTLV-1 with special emphasis on African genotypes.

Authors:  Philippe V Afonso; Olivier Cassar; Antoine Gessain
Journal:  Retrovirology       Date:  2019-12-16       Impact factor: 4.602

9.  Human T-lymphotropic virus 1aA circulation and risk factors for sexually transmitted infections in an Amazon geographic area with lowest human development index (Marajó Island, Northern Brazil).

Authors:  Samantha Assis de Aguiar; Samires Avelino de Souza França; Barbara Brasil Santana; Mike Barbosa Santos; Felipe Bonfim Freitas; Glenda Ferreira; Izaura Cayres-Vallinoto; Marluísa O G Ishak; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  BMC Infect Dis       Date:  2017-12-08       Impact factor: 3.090

10.  Low genetic diversity of the Human T-cell Lymphotropic Virus (HTLV-1) in an endemic area of the Brazilian Amazon basin.

Authors:  Akim Felipe Santos Nobre; Danilo de Souza Almeida; Louise Canto Ferreira; Deimy Lima Ferreira; Edivaldo Costa Sousa Júnior; Maria de Nazaré do Socorro de Almeida Viana; Ingrid Christiane Silva; Bruna Teles Pinheiro; Stephen Francis Ferrari; Alexandre da Costa Linhares; Edna Aoba Ishikawa; Rita Catarina Medeiros Sousa; Maísa Silva de Sousa
Journal:  PLoS One       Date:  2018-03-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.